Common misconceptions about data analysis and statistics

Journal of Pharmacology and Experimental Therapeutics

Volumn 351, Issue 1, 2014, Pages 200-205

  Motulsky, Harvey J ^a  

^a GraphPad Software   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONFIDENCE INTERVAL; CORRELATION COEFFICIENT; DATA ANALYSIS; EFFECT SIZE; INFORMATION PROCESSING; MULTIPLE REGRESSION; NORMAL DISTRIBUTION; NULL HYPOTHESIS; P HACKING; SAMPLE SIZE; SAMPLING; SAMPLING ERROR; STATISTICAL ANALYSIS; STATISTICAL BIAS; STATISTICAL HYPOTHESIS TESTING; STATISTICAL SIGNIFICANCE; STATISTICS; BIOSTATISTICS; PROCEDURES; REPRODUCIBILITY;

BIOSTATISTICS; DATA INTERPRETATION, STATISTICAL; REPRODUCIBILITY OF RESULTS;

EID: 84907164370     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.114.219170     Document Type: Article

References (17)

1. Anonymous (2013). Trouble at the lab. The Economist 409:23-27.
2. Collins FS and Tabak LA (2014) Policy: NIH plans to enhance reproducibility. Nature 505:612-613.
3. Begley CG and Ellis LM (2012) Drug development: Raise standards for preclinical cancer research. Nature 483:531-533.
4. Berry DA (2007) The difficult and ubiquitous problems of multiplicities. Pharm Stat 6:155-160.
5. Cohen J (1994) The earth is round (p < 0.05). Am Psychol 49:997-1003.
6. Colquhoun D (2014) An investigation of the false discovery rate and the misinterpretation of P values [article online]. arXiv:1407.5296 (available from http://arxiv.org/abs/1407.5296).
7. Food and Drug Administration (2010) Guidance for industry: adaptive design clinical trials for drugs and biologics. Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
8. Ioannidis JPA (2005) Why most published research findings are false. PLoS Med 2:e124.
9. Kairalla JA, Coffey CS, Thomann MA, and Muller KE (2012) Adaptive trial designs: a review of barriers and opportunities. Trials 13:145.
10. Kerr NL (1998) HARKing: hypothesizing after the results are known. Pers Soc Psychol Rev 2:196-217.
11. Kriegeskorte N, Simmons WK, Bellgowan PSF, and Baker CI (2009) Circular analysis in systems neuroscience: the dangers of double dipping. Nat Neurosci 12:535-540.
12. Marino MJ (2014) The use and misuse of statistical methodologies in pharmacology research. Biochem Pharmacol 87:78-92.
13. Motulsky HJ (2014a) Intuitive Biostatistics, 3rd ed, Oxford University Press, New York.
14. Motulsky HJ (2014b) Opinion: never use the word "significant" in a scientific paper. Advances Regenerative Biol 1:25155, in press DOI: 10.3402/arb.v1.25155.
15. Prinz F, Schlange T, and Asadullah K (2011) Believe it or not: how much can we rely on published data on potential drug targets? Nat Rev Drug Discov 10:712-713.
16. Simmons JP, Nelson LD, and Simonsohn U (2011) False-positive psychology: undisclosed flexibility in data collection and analysis allows presenting anything as significant. Psychol Sci 22:1359-1366.
17. Ziliak S and McCloskey DN (2008) The Cult of Statistical Significance: How the Standard Error Costs Us Jobs, Justice, and Lives, University of Michigan Press, Ann Arbor, MI.